Hematopoietic Stem Cell Transplantation from Haploidentical Donors in Aplasia after Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

ConclusionWe found that sequential therapy with HCT in aplasia after cladribine/cytarabine chemotherapy is feasible, results in high CR rates and has acceptable toxicity profile, however, post-transplant relapse is common in patients treated with active disease.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research